본문 바로가기
KERD
논문KCI 등재

How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies

함병주|한규만
대한신경과학회 (Korean Neurological Association)|2021.10|Journal of Clinical Neurology|제17권 제4호|pp. 503-515|DOI 10.3988/jcn.2021.17.4.503

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

depressionmajor depressive disorderinflammationmagnetic resonance imagingneuroimaging.

초록

This narrative review discusses how peripheral and central inflammation processes affect brain function and structure in depression, and reports on recent peripheral inflammatory marker-based functional and structural magnetic resonance imaging (MRI) studies from the perspective of neural-circuit dysfunction in depression. Chronic stress stimulates the activity of microglial cells, which increases the production of pro-inflammatory cytokines in the brain. In addition, microglial activation promotes a shift from the synthesis of serotonin to the synthesis of neurotoxic metabolites of the kynurenine pathway, which induces glutamatemediated excitotoxicity in neurons. Furthermore, the region specificity of microglial activation is hypothesized to contribute to the vulnerability of specific brain regions in the depressionrelated neural circuits to inflammation-mediated brain injury. MRI studies are increasingly investigating how the blood levels of inflammatory markers such as C-reactive protein, interleukin (IL)-1β, IL-6, and tumor necrosis factor-α are associated with functional and structural neuroimaging markers in depression. Functional MRI studies have found that peripheral inflammatory markers are associated with aberrant activation patterns and altered functional connectivity in neural circuits involved in emotion regulation, reward processing, and cognitive control in depression. Structural MRI studies have suggested that peripheral inflammatory markers are related to reduced cortical gray matter and subcortical volumes, cortical thinning, and decreased integrity of white matter tracts within depression-related neural circuits. These neuroimaging findings may improve our understanding of the relationships between neuroinflammatory processes at the molecular level and macroscale in vivo neuralcircuit dysfunction in depression

Abstract

This narrative review discusses how peripheral and central inflammation processes affect brain function and structure in depression, and reports on recent peripheral inflammatory marker-based functional and structural magnetic resonance imaging (MRI) studies from the perspective of neural-circuit dysfunction in depression. Chronic stress stimulates the activity of microglial cells, which increases the production of pro-inflammatory cytokines in the brain. In addition, microglial activation promotes a shift from the synthesis of serotonin to the synthesis of neurotoxic metabolites of the kynurenine pathway, which induces glutamatemediated excitotoxicity in neurons. Furthermore, the region specificity of microglial activation is hypothesized to contribute to the vulnerability of specific brain regions in the depressionrelated neural circuits to inflammation-mediated brain injury. MRI studies are increasingly investigating how the blood levels of inflammatory markers such as C-reactive protein, interleukin (IL)-1β, IL-6, and tumor necrosis factor-α are associated with functional and structural neuroimaging markers in depression. Functional MRI studies have found that peripheral inflammatory markers are associated with aberrant activation patterns and altered functional connectivity in neural circuits involved in emotion regulation, reward processing, and cognitive control in depression. Structural MRI studies have suggested that peripheral inflammatory markers are related to reduced cortical gray matter and subcortical volumes, cortical thinning, and decreased integrity of white matter tracts within depression-related neural circuits. These neuroimaging findings may improve our understanding of the relationships between neuroinflammatory processes at the molecular level and macroscale in vivo neuralcircuit dysfunction in depression

참고문헌 (128)

  1. Bromet E, "Cross-national epidemiology of DSM-IV major depressive episode", BMC Med, 9, pp.90~ (2011)
  2. Global Burden of Disease Study 2013 Collaborators, "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013 : a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 386, pp.743~800 (2015)
  3. Lerner D, "What does research tell us about depression, job performance, and work productivity?", J Occup Environ Med, 50, pp.401~410 (2008)
  4. Gaynes BN, "Depression and health-related quality of life", J Nerv Ment Dis, 190, pp.799~806 (2002)
  5. Han KM, "Relationship of depression, chronic disease, self-rated health, and gender with health care utilization among community-living elderly", J Affect Disord, 241, pp.402~410 (2018)
  6. Cuijpers P, "Differential mortality rates in major and subthreshold depression : meta-analysis of studies that measured both", Br J Psychiatry, 202, pp.22~27 (2013)
  7. Otte C, "Major depressive disorder", Nat Rev Dis Primers, 2, pp.16065~ (2016)
  8. Kupfer DJ, "Major depressive disorder : new clinical, neurobiological, and treatment perspectives", Lancet, 379, pp.1045~1055 (2012)
  9. 최수정, "Insomnia Symptoms and Mood Disturbances in Shift Workers with Different Chronotypes and Working Schedules", Journal of Clinical Neurology, 16(1), pp.108~115 (2020), 대한신경과학회
  10. 박윤경, "Altered Regional Cerebral Blood Flow Associated with Mood and Sleep in Shif Workers: Cerebral Perfusion Magnetic Resonance Imaging Study", Journal of Clinical Neurology, 15(4), pp.438~447 (2019), 대한신경과학회
  11. 선우준상, "Comorbid Depression Is Associated with a Negative Treatment Response in Idiopathic REM Sleep Behavior Disorder", Journal of Clinical Neurology, 16(2), pp.261~269 (2020), 대한신경과학회
  12. 김미나, "Association between Stroke Status and Depression in a Community Setting: The 2014 Korea National Health and Nutrition Examination Survey", Journal of Clinical Neurology, 13(1), pp.55~61 (2017), 대한신경과학회[DOI]
  13. Han KM, "Development of Neuroimaging-Based Biomarkers in Major Depression", Adv Exp Med Biol, 1305, pp.85~99 (2021)
  14. Miller AH, "Inflammation and its discontents : the role of cytokines in the pathophysiology of major depression", Biol Psychiatry, 65, pp.732~741 (2009)
  15. Woelfer M, "The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder", Neuroscience, 403, pp.93~110 (2019)
  16. Berk M, "So depression is an inflammatory disease, but where does the inflammation come from?", BMC Med, 11, pp.200~ (2013)
  17. Martin-Subero M, "Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress;tryptophan catabolite; and gut-brain pathways", CNS Spectr, 21, pp.184~198 (2016)
  18. Jiang M, "Comorbidity between depression and asthma via immune-inflammatory pathways : a meta-analysis", J Affect Disord, 166, pp.22~29 (2014)
  19. Matcham F, "The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis", Rheumatology(Oxford), 52, pp.2136~2148 (2013)
  20. Pashaki MS, "The prevalence of comorbid depression in patients with diabetes : a meta-analysis of observational studies", Diabetes Metab Syndr, 13, pp.3113~3119 (2019)
  21. Greten FR, "Inflammation and cancer : triggers, mechanisms, and consequences", Immunity, 51, pp.27~41 (2019)
  22. Kim JS, "1α, 25-Dihydroxyvitamin D3 protects dopaminergic neurons in rodent models of Parkinson’s disease through inhibition of microglial activation", J Clin Neurol, 2, pp.252~257 (2006)
  23. Hirsch EC, "Ten unsolved questions about neuroinflammation in Parkinson’s disease", Mov Disord, 36, pp.16~24 (2021)
  24. Filippi M, "Multiple sclerosis", Nat Rev Dis Primers, 4, pp.43~ (2018)
  25. Crotti A, "The choreography of neuroinflammation in Huntington’s disease", Trends Immunol, 36, pp.364~373 (2015)
  26. Calsolaro V, "Neuroinflammation in Alzheimer’s disease : current evidence and future directions", Alzheimers Dement, 12, pp.719~732 (2016)
  27. Jingwei Shang, "Different Associations of Plasma Biomarkers in Alzheimer’s Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke", Journal of Clinical Neurology, 14(1), pp.29~34 (2018), 대한신경과학회[DOI]
  28. Simone Vidale, "Postischemic Inflammation in Acute Stroke", Journal of Clinical Neurology, 13(1), pp.1~9 (2017), 대한신경과학회[DOI]
  29. Han KM, "Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder : a longitudinal study based on 4. 7 million adults in South Korea", J Affect Disord, 257, pp.486~494 (2019)
  30. Hoyo-Becerra C, "Insights from interferonα-related depression for the pathogenesis of depression associated with inflammation", Brain Behav Immun, 42, pp.222~231 (2014)
  31. Goldsmith DR, "A meta-analysis of blood cytokine network alterations in psychiatric patients : comparisons between schizophrenia, bipolar disorder and depression", Mol Psychiatry, 21, pp.1696~1709 (2016)
  32. Köhler CA, "Peripheral cytokine and chemokine alterations in depression : a meta-analysis of 82 studies", Acta Psychiatr Scand, 135, pp.373~387 (2017)
  33. Osimo EF, "Inflammatory markers in depression : a meta-analysis of mean differences and variability in 5, 166 patients and 5, 083 controls", Brain Behav Immun, 87, pp.901~909 (2020)
  34. Raison CL, "Cytokines sing the blues : inflammation and the pathogenesis of depression", Trends Immunol, 27, pp.24~31 (2006)
  35. Chourbaji S, "IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors", Neurobiol Dis, 23, pp.587~594 (2006)
  36. Simen BB, "TNFα signaling in depression and anxiety : behavioral consequences of individual receptor targeting", Biol Psychiatry, 59, pp.775~785 (2006)
  37. Kim YK, "The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder", Behav Brain Res, 329, pp.6~11 (2017)
  38. Felger JC, "Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression", Mol Psychiatry, 21, pp.1358~1365 (2016)
  39. Meier TB, "Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder", Brain Behav Immun, 53, pp.39~48 (2016)
  40. Troubat R, "Neuroinflammation and depression : a review", Eur J Neurosci, 53, pp.151~171 (2021)
  41. Varatharaj A, "The blood-brain barrier in systemic inflammation", Brain Behav Immun, 60, pp.1~12 (2017)
  42. Kaufmann FN, "NLRP3 inflammasome-driven pathways in depression : clinical and preclinical findings", Brain Behav Immun, 64, pp.367~383 (2017)
  43. Won E, "Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders", Int J Mol Sci, 21, pp.6546~ (2020)
  44. Hamon M, "Monoamine neurocircuitry in depression and strategies for new treatments", Prog Neuropsychopharmacol Biol Psychiatry, 45, pp.54~63 (2013)
  45. Moylan S, "The neuroprogressive nature of major depressive disorder : pathways to disease evolution and resistance, and therapeutic implications", Mol Psychiatry, 18, pp.595~606 (2013)
  46. Mithaiwala MN, "Neuroinflammation and the kynurenine pathway in CNS disease : molecular mechanisms and therapeutic implications", Cells, 10, pp.1548~ (2021)
  47. Brown SJ, "The kynurenine pathway in major depression : what we know and where to next", Neurosci Biobehav Rev, 127, pp.917~927 (2021)
  48. Wolfgang Marx, "The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies", Molecular Psychiatry, 26(8), pp.4158~4178 (2021), Springer Science and Business Media LLC[DOI]
  49. Schiavone S, "The NADPH oxidase NOX2 as a novel biomarker for suicidality : evidence from human post mortem brain samples", Transl Psychiatry, 6, pp.e813~ (2016)
  50. Baharikhoob P, "Microglial dysregulation and suicidality : a stress-diathesis perspective", Front Psychiatry, 11, pp.781~ (2020)
  51. Torres-Platas SG, "Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides", Brain Behav Immun, 42, pp.50~59 (2014)
  52. Schnieder TP, "Microglia of prefrontal white matter in suicide", J Neuropathol Exp Neurol, 73, pp.880~890 (2014)
  53. Enache D, "Markers of central inflammation in major depressive disorder : a systematic review and metaanalysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue", Brain Behav Immun, 81, pp.24~40 (2019)
  54. Steiner J, "Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus : evidence for an immune-modulated glutamatergic neurotransmission?", J Neuroinflammation, 8, pp.94~ (2011)
  55. Gritti D, "Neuroinflammation in major depressive disorder : a review of PET imaging studies examining the 18-kDa translocator protein", J Affect Disord, 292, pp.642~651 (2021)
  56. Papadopoulos V, "Translocator protein(18kDa) : new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function", Trends Pharmacol Sci, 27, pp.402~409 (2006)
  57. Liu GJ, "The 18kDa translocator protein, microglia and neuroinflammation", Brain Pathol, 24, pp.631~653 (2014)
  58. Setiawan E, "Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes", JAMA Psychiatry, 72, pp.268~275 (2015)
  59. Su L, "Neuroinflammatory and morphological changes in late-life depression : the NIMROD study", Br J Psychiatry, 209, pp.525~526 (2016)
  60. Holmes SE, "Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking : a positron emission tomography study", Biol Psychiatry, 83, pp.61~69 (2018)
  61. Li H, "Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder", J Affect Disord, 241, pp.305~310 (2018)
  62. Richards EM, "PET radioligand binding to translocator protein(TSPO)is increased in unmedicated depressed subjects", EJNMMI Res, 8, pp.57~ (2018)
  63. Setiawan E, "Association of translocator protein total distribution volume with duration of untreated major depressive disorder : a cross-sectional study", Lancet Psychiatry, 5, pp.339~347 (2018)
  64. Li H, "Translocator protein(18kDa TSPO)binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy", Prog Neuropsychopharmacol Biol Psychiatry, 83, pp.1~7 (2018)
  65. Haroon E, "IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy", Neuropsychopharmacology, 39, pp.1777~1785 (2014)
  66. Haroon E, "Conceptual convergence : increased inflammation is associated with increased basal ganglia glutamate in patients with major depression", Mol Psychiatry, 21, pp.1351~1357 (2016)
  67. Taylor MJ, "Effect of interferon-α on cortical glutamate in patients with hepatitis C : a proton magnetic resonance spectroscopy study", Psychol Med, 44, pp.789~795 (2014)
  68. Haroon E, "Inflammation, glutamate, and glia : a trio of trouble in mood disorders", Neuropsychopharmacology, 42, pp.193~215 (2017)
  69. Anacker C, "Adult hippocampal neurogenesis and cognitive flexibility-linking memory and mood", Nat Rev Neurosci, 18, pp.335~346 (2017)
  70. Malykhin NV, "Hippocampal neuroplasticity in major depressive disorder", Neuroscience, 309, pp.200~213 (2015)
  71. Leuner B, "Structural plasticity and hippocampal function", Annu Rev Psychol, 61, pp.111~140 (2010)
  72. Balu DT, "Adult hippocampal neurogenesis : regulation, functional implications, and contribution to disease pathology", Neurosci Biobehav Rev, 33, pp.232~252 (2009)
  73. Hill AS, "Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors", Neuropsychopharmacology, 40, pp.2368~2378 (2015)
  74. Schmaal L, "Subcortical brain alterations in major depressive disorder : findings from the ENIGMA Major Depressive Disorder Working Group", Mol Psychiatry, 21, pp.806~812 (2016)
  75. Geerlings MI, "Late-life depression, hippocampal volumes, and hypothalamic-pituitary-adrenal axis regulation : a systematic review and meta-analysis", Biol Psychiatry, 82, pp.339~350 (2017)
  76. Fujioka H, "Lipopolysaccharide acutely inhibits proliferation of neural precursor cells in the dentate gyrus in adult rats", Brain Res, 1352, pp.35~42 (2010)
  77. Zonis S, "p21Cip restrains hippocampal neurogenesis and protects neuronal progenitors from apoptosis during acute systemic inflammation", Hippocampus, 23, pp.1383~1394 (2013)
  78. Zheng LS, "Mechanisms for interferon-α-induced depression and neural stem cell dysfunction", Stem Cell Reports, 3, pp.73~84 (2014)
  79. Kaneko N, "Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus", Neuropsychopharmacology, 31, pp.2619~2626 (2006)
  80. Koo JW, "IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress", Proc Natl Acad Sci U S A, 105, pp.751~756 (2008)
  81. Green HF, "A role for interleukin-1β in determining the lineage fate of embryonic rat hippocampal neural precursor cells", Mol Cell Neurosci, 49, pp.311~321 (2012)
  82. Ryan SM, "Negative regulation of TLX by IL-1β correlates with an inhibition of adult hippocampal neural precursor cell proliferation", Brain Behav Immun, 33, pp.7~13 (2013)
  83. Chien-Han Lai, "Promising Neuroimaging Biomarkers in Depression", PSYCHIATRY INVESTIGATION, 16(9), pp.662~670 (2019), 대한신경정신의학회[DOI]
  84. Williams LM, "Defining biotypes for depression and anxiety based on large-scale circuit dysfunction : a theoretical review of the evidence and future directions for clinical translation", Depress Anxiety, 34, pp.9~24 (2017)
  85. Williams LM, "Precision psychiatry : a neural circuit taxonomy for depression and anxiety", Lancet Psychiatry, 3, pp.472~480 (2016)
  86. Phillips ML, "Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder : neuroimaging approaches", Am J Psychiatry, 172, pp.124~138 (2015)
  87. Kim YK, "Neural substrates for late-life depression : a selective review of structural neuroimaging studies", Prog Neuropsychopharmacol Biol Psychiatry, 104, pp.110010~ (2021)
  88. Zhu X, "Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients", Biol Psychiatry, 71, pp.611~617 (2012)
  89. Zhou HX, "Rumination and the default mode network : meta-analysis of brain imaging studies and implications for depression", Neuroimage, 206, pp.116287~ (2020)
  90. Hamilton JP, "Default-mode and task-positive network activity in major depressive disorder : implications for adaptive and maladaptive rumination", Biol Psychiatry, 70, pp.327~333 (2011)
  91. Harrison NA, "Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity", Biol Psychiatry, 66, pp.407~414 (2009)
  92. Harrison NA, "A neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards", Biol Psychiatry, 80, pp.73~81 (2016)
  93. Eisenberger NI, "Inflammation-induced anhedonia : endotoxin reduces ventral striatum responses to reward", Biol Psychiatry, 68, pp.748~754 (2010)
  94. Dipasquale O, "Interferon-α acutely impairs whole-brain functional connectivity network architecture-a preliminary study", Brain Behav Immun, 58, pp.31~39 (2016)
  95. Muscatell KA, "Greater amygdala activity and dorsomedial prefrontalamygdala coupling are associated with enhanced inflammatory responses to stress", Brain Behav Immun, 43, pp.46~53 (2015)
  96. Slavich GM, "Neural sensitivity to social rejection is associated with inflammatory responses to social stress", Proc Natl Acad Sci U S A, 107, pp.14817~11422 (2010)
  97. Conejero I, "Association between baseline pro-inflammatory cytokines and brain activation during social exclusion in patients with vulnerability to suicide and depressive disorder", Psychoneuroendocrinology, 99, pp.236~242 (2019)
  98. Mocking RJT, "Biological profiling of prospective antidepressant response in major depressive disorder : associations with(neuro)inflammation, fatty acid metabolism, and amygdala-reactivity", Psychoneuroendocrinology, 79, pp.84~92 (2017)
  99. Young KD, "Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression", Brain Behav Immun, 56, pp.335~342 (2016)
  100. Yin L, "Inflammation and decreased functional connectivity in a widely-distributed network in depression : centralized effects in the ventral medial prefrontal cortex", Brain Behav Immun, 80, pp.657~666 (2019)
  101. Mehta ND, "Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression : preliminary results", Brain Behav Immun, 73, pp.725~730 (2018)
  102. Burrows K, "Elevated peripheral inflammation is associated with attenuated striatal reward anticipation in major depressive disorder", Brain Behav Immun, 93, pp.214~225 (2021)
  103. Sumner JA, "Overgeneral autobiographical memory as a predictor of the course of depression : a meta-analysis", Behav Res Ther, 48, pp.614~625 (2010)
  104. Wang W, "Conjoint and dissociated structural and functional abnormalities in first-episode drug-naive patients with major depressive disorder : a multimodal meta-analysis", Sci Rep, 7, pp.10401~ (2017)
  105. Sacher J, "Mapping the depressed brain : a meta-analysis of structural and functional alterations in major depressive disorder", J Affect Disord, 140, pp.142~148 (2012)
  106. Gray JP, "Multimodal abnormalities of brain structure and function in major depressive disorder : a meta-analysis of neuroimaging studies", Am J Psychiatry, 177, pp.422~434 (2020)
  107. Byrne ML, "The role of brain structure and function in the association between inflammation and depressive symptoms : a systematic review", Psychosom Med, 78, pp.389~400 (2016)
  108. Savitz J, "Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder", Psychoneuroendocrinology, 62, pp.54~58 (2015)
  109. Belge JB, "Inflammation, hippocampal volume, and therapeutic outcome following electroconvulsive therapy in depressive patients : a pilot study", Neuropsychobiology, 79, pp.222~232 (2020)
  110. Zhou YL, "Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder", J Affect Disord, 276, pp.608~615 (2020)
  111. Smagula SF, "Immunological biomarkers associated with brain structure and executive function in late-life depression : exploratory pilot study", Int J Geriatr Psychiatry, 32, pp.692~699 (2017)
  112. Chen MH, "Increased proinflammatory cytokines, executive dysfunction, and reduced gray matter volumes in first-episode bipolar disorder and major depressive disorder", J Affect Disord, 274, pp.825~831 (2020)
  113. Gu Y, "Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population", Brain Behav Immun, 65, pp.150~160 (2017)
  114. Han KM, "Serum FAM19A5 levels : a novel biomarker for neuroinflammation and neurodegeneration in major depressive disorder", Brain Behav Immun, 87, pp.852~859 (2020)
  115. Schmaal L, "Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group", Mol Psychiatry, 22, pp.900~909 (2017)
  116. Damoiseaux JS, "Greater than the sum of its parts : a review of studies combining structural connectivity and resting-state functional connectivity", Brain Struct Funct, 213, pp.525~533 (2009)
  117. Honey CJ, "Predicting human resting-state functional connectivity from structural connectivity", Proc Natl Acad Sci U S A, 106, pp.2035~2040 (2009)
  118. Greicius MD, "Resting-state functional connectivity reflects structural connectivity in the default mode network", Cereb Cortex, 19, pp.72~78 (2009)
  119. 태우석, "Current Clinical Applications of Diffusion-Tensor Imaging in Neurological Disorders", Journal of Clinical Neurology, 14(2), pp.129~140 (2018), 대한신경과학회[DOI]
  120. Sugimoto K, "Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder : diffusion tensor imaging study using tract-based spatial statistics", Transl Psychiatry, 8, pp.141~ (2018)
  121. van Velzen LS, "White matter disturbances in major depressive disorder : a coordinated analysis across 20 international cohorts in the ENIGMA MDD Working Group", Mol Psychiatry, 25, pp.1511~1525 (2020)
  122. MacQueen GM, "Course of illness, hippocampal function, and hippocampal volume in major depression", Proc Natl Acad Sci U S A, 100, pp.1387~1392 (2003)
  123. Liu CH, "Role of inflammation in depression relapse", J Neuroinflammation, 16, pp.90~ (2019)
  124. Carlessi AS, "Gut microbiota-brain axis in depression : the role of neuroinflammation", Eur J Neurosci, 53, pp.222~235 (2021)
  125. Barnes J, "Genetic contributions of inflammation to depression", Neuropsychopharmacology, 42, pp.81~98 (2017)
  126. Green C, "Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder", Brain Behav Immun, 92, pp.39~48 (2021)
  127. Bai S, "Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder : a systematic review and meta-analysis of randomised controlled trials", J Neurol Neurosurg Psychiatry, 91, pp.21~32 (2020)
  128. Fernandes BS, "The new field of ‘precision psychiatry’", BMC Med, 15, pp.80~ (2017)

관련 논문AI추천

Inflammation as the Potential Basis in Depression맹성호, 홍희옥대한배뇨장애요실금학회 · International Neurourology Journal2019 · 제23권 제4호Neuroinflammation, Gut-Brain Axis and DepressionAlper Evrensel, Barıs¸ Önen Ünsalver, Mehmet Emin Ceylan대한신경정신의학회 · PSYCHIATRY INVESTIGATION2020 · 제17권 제1호White Matter Alterations Associated with Pro-inflammatory Cytokines in Patients with Major Depressive Disorder김보라, Hoyoung Sohn, Jaehwa Lim, Min-Soo Kwon대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제3호Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response김도관, 명우재, 박진홍, 심상홍, 우혜인, 임신원, Soo-Youn Lee대한신경정신의학회 · PSYCHIATRY INVESTIGATION2016 · 제13권 제6호Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders김병선, 임혜인, 홍희옥대한배뇨장애요실금학회 · International Neurourology Journal2016 · 제20권 제1호Biomarkers of Major Depressive Disorder: Knowing is Half the BattleAkriti Dangol, Govind Arora, Ravinder Singh, Sahil Malik, Sanjay Goyal대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제1호

이 간행물의 다른 논문 (22건)

Hyperintense Vessel Sign in Large-Vessel Occlusion Stroke of Mild-to-Moderate Severity Ineligible for Recanalization정상욱, 류위선, 윤호상, 김동억pp. 516-523Incidence and Reappraisal of Known Risk Factors Associated with Carpal Tunnel Syndrome: A Nationwide, 11-Year, Population-Based Study in South Korea김형섭, 김종훈, Rhee Seung Yeon, Han Eol Chopp. 524-533A Compound Heterozygous Pathogenic Variant in B4GALNT1 Is Associated With Axonal Charcot-Marie-Tooth Disease홍지만, 전혜진, 최영철, 박형준, 조한나, 홍영빈pp. 534-540Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic ReviewQuintans-Júnior Lucindo José, de Souza Araújo Adriano Antunes, Nunes Paula Santos, Santos Victor Santana, Ferreira Lis Campos, de Aquino Neves Eduardo Luis, Martins-Filho Paulo Ricardo, Pereira de Andrade Ana Luiza, Pereira de Andrade Ana Júlia, Moura da Silva Maria Daniellapp. 541-545Disability and Economic Loss Caused by Headache Among Information Technology Workers in Korea김병건, Fumihiko Sakai, David W. Dodick, 조수진, 김창수, 주민경pp. 546-557
원문 보기